CLINICAL_TRIALS
trial_result
· 2012-06-13
Clinical Trial Update: ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) [Phase 2]
Summary
A Phase 2 study evaluating ALKS 37 (RDC-1036) for opioid-induced constipation in adults has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Opioid-induced Constipation | Phase 2 | Status: COMPLETED